Literature DB >> 596102

Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man.

D S Schade, P R Eaton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 596102     DOI： 10.1007/bf02624664

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  16 in total

1.  Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma.

Authors:  S L Lightman; S R Bloom
Journal:  Br Med J       Date:  1974-03-02

2.  Effect of glucagon: insulin ratios on hepatic metabolism.

Authors:  R Parrilla; M N Goodman; C J Toews
Journal:  Diabetes       Date:  1974-09       Impact factor: 9.461

3.  Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions.

Authors:  W G Blackard; N C Nelson; S S Andrews
Journal:  Diabetes       Date:  1974-03       Impact factor: 9.461

4.  Relationship between fat and ketone body metabolism in obese and nonobese diabetics and nondiabetics during norepinephrine infusion.

Authors:  B Willms; M Böttcher; V Wolters; N Sakamoto; H D Söling
Journal:  Diabetologia       Date:  1969-04       Impact factor: 10.122

5.  Transfer of plasma lipid to platelets by action of glucagon.

Authors:  R Caren; L Corbo
Journal:  Metabolism       Date:  1970-08       Impact factor: 8.694

6.  Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes       Date:  1975-05       Impact factor: 9.461

7.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

8.  Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes       Date:  1975-05       Impact factor: 9.461

9.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Inhibition of insulin release by norepinephrine in man.

Authors:  D Porte; R H Williams
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728
View more
  1 in total

1.  Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects.

Authors:  E Bonora; P Moghetti; V Cacciatori; M Zenere; F Tosi; D Travia; G Zoppini; L Perobelli; M Muggeo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.